Compare Heron Therapeutics Inc (HRTX) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Star Bulk Carriers Corp — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Star Bulk Carriers Corp trades at $26.38 (market cap $2.91B). The key difference: Star Bulk Carriers Corp is far larger — about 31.8× Heron Therapeutics Inc's market cap, and Star Bulk Carriers Corp pays a 3.95% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | SBLK | |
|---|---|---|
Market Cap | $91.46M | $2.91B |
Sector | Health | Industrials |
52-Week High | $1.96 | $28.21 |
52-Week Low | $0.39 | $16.79 |
Enterprise Value | $189.36M | $3.61B |
Dividend Yield | — | 3.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
Star Bulk Carriers (SBLK) trades at $26.09, up 4.78% in the last session. Technical indicators are bearish, but fundamentals show strength with a P/E of 19.92 and net income margin of 13.01%. Recent earnings beat expectations in Q4 2025 and Q1 2026, with Q2 2026 EPS expected at $0.96. The company maintains a healthy balance sheet and pays dividends, including a recent $0.50 per share distribution.
Outlook is cautiously optimistic due to strong dry bulk rates and fleet modernization driving cash flow. Risks include shipping rate volatility and macroeconomic pressures. Analyst consensus is bullish with 58.34% buy ratings, but technical weakness suggests near-term caution. The stock offers value with a 10%+ dividend yield potential if rates sustain.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
